Vicore Pharma Holding AB
VCRE | NASDAQ
$9.59
-$0.21 (-2.14%)
Nov 2, 2026, 3:03 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 228.25K | 602K | 419K | 80.73K | 1.75M | 892K | 461.23K | n/a | n/a | 9.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 554.32K | 832.84K | n/a | 51.08M | 840.48K | 836.35K | 896.89K | 881.47K | 903.06K | 900.77K | 895.8K | n/a | 899.55K |
Gross Profit | 228.25K | 602K | 419K | 80.73K | 1.75M | 892K | 461.23K | -554.32K | -832.84K | 9.76M | -51.08M | -840.48K | -836.35K | -896.89K | -881.47K | -903.06K | -900.77K | -895.8K | n/a | -899.55K |
Operating Income | -15.48M | -123.85M | -133.71M | -12.32M | -111.17M | -91.55M | -8.5M | -178.07M | -178.1M | -169.98M | -302.71M | -296.71M | -297.23M | -297.12M | -268.2M | -268.44M | -268.5M | -272.07M | -8.96M | -11.17M |
Interest Income | n/a | 15.96M | 5.15M | 264.37K | 10.31M | 6.42M | 523.14K | 11.32K | 633.49K | 792.01K | 886.05K | 128.15K | 46.36K | n/a | 118.37K | 96.94K | n/a | n/a | 370K | 10.17K |
Pretax Income | -14.71M | -108.53M | -137.1M | -12.05M | -115.36M | -111.54M | -7.6M | -158.93M | -158.34M | -150.06M | -292.68M | -287.4M | -288M | -287.97M | -266.24M | -266.59M | -266.86M | -270.35M | -8.88M | -11.16M |
Net Income | -14.73M | -108.62M | -137.1M | -12.05M | -115.36M | -111.54M | -7.6M | -59.23M | -5.32M | 2.97M | 551.36M | -5.82M | -6.42M | -6.39M | -59.25M | -6.17M | -6.44M | -92.63M | -8.89M | -97.18M |
Selling & General & Admin | 3.41M | 21.51M | 22.06M | 1.87M | 14.08M | 14.13M | 1.53M | 10.76M | 12.62M | 9.95M | 16.47M | 10.37M | 8.79M | 8.78M | 7.65M | 847K | 9.84M | 10.35M | 716.46K | 676.15K |
Research & Development | 12.26M | 102.6M | 113.04M | 10.53M | 99.42M | 78.73M | 7.38M | 48.31M | 48.82M | 67.81M | 52.52M | 54.26M | 59.31M | 55.37M | 52.67M | 5.41M | 53.54M | 78.94M | 8.21M | 10.45M |
Other Expenses | 46.41K | 340K | -975K | -9.35K | -579K | -417K | 57.03K | n/a | n/a | -70.17M | n/a | n/a | n/a | n/a | n/a | 62.3M | n/a | n/a | 34.05K | 85M |
Operating Expenses | 15.71M | 124.45M | 134.13M | 12.4M | 112.92M | 92.44M | 8.97M | 59.07M | 61.44M | 7.59M | 69M | 64.63M | 68.09M | 64.16M | 60.31M | 68.56M | 63.38M | 89.29M | 8.96M | 96.13M |
Interest Expense | 103 | 643K | 8.55M | n/a | 14.5M | 26.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.81K | n/a | n/a | 108.4K | 31.58K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 183.75K | 194.69K | 179.31K | 169.37K | 151.05K | 148.03K | 268.12K | 338.88K | 155.21K | n/a |
Cost & Expenses | 15.71M | 124.45M | 134.13M | 12.4M | 112.92M | 92.44M | 8.97M | 5.92M | 5.96M | 7.59M | 302.71M | 296.71M | 297.23M | 297.12M | 268.2M | 268.44M | 268.5M | 272.07M | 8.96M | 11.17M |
Income Tax Expense | 17.84K | 86K | n/a | n/a | n/a | n/a | n/a | -63.24K | -95.29K | -96.66K | -95.41K | -96.06K | -95.7K | -95.35K | -93.71K | -96.01K | -95.76K | -95.23K | 9.73K | -113.56K |
Shares Outstanding (Basic) | 280.09M | 28.15M | 25.58M | 234.61M | 23.46M | 23.46M | 216.05M | 111.73M | 111.73M | 111.72M | 111.72M | 108.77M | 81.85M | 81.85M | 73.49M | 71.85M | 71.76M | 71.76M | 71.76M | 71.76M |
Shares Outstanding (Diluted) | 280.09M | 28.15M | 25.58M | 234.61M | 23.46M | 23.46M | 216.05M | 111.73M | 111.73M | 111.72M | 111.72M | 108.77M | 81.85M | 81.85M | 73.49M | 71.85M | 71.76M | 71.76M | 71.76M | 71.76M |
EPS (Basic) | -0.05 | -3.90 | -5.40 | -0.05 | -4.90 | -4.80 | -0.04 | -0.05 | -0.05 | 0.03 | -0.10 | -0.05 | -0.08 | -0.08 | -0.08 | -0.09 | -0.09 | -0.14 | -0.12 | -0.16 |
EPS (Diluted) | -0.05 | -3.90 | -5.40 | -0.05 | -4.90 | -4.80 | -0.04 | -0.05 | -0.05 | 0.03 | -0.10 | -0.05 | -0.08 | -0.08 | -0.08 | -0.09 | -0.09 | -0.14 | -0.12 | -0.16 |
EBITDA | n/a | -107.89M | -128.56M | -12.27M | -100.86M | -85.13M | -8.45M | -5.89M | -5.84M | -146.46M | -290.53M | -4.81M | -6.33M | -6.22M | -5.92M | -6.18M | -6.21M | -9.57M | -8.86M | -11.03M |
EBIT | -15.48M | -107.89M | -128.56M | -12.33M | -100.86M | -85.13M | -8.45M | -5.94M | -62.27M | -148.57M | -292.61M | -65.47M | -68.93M | -65.05M | -61.19M | -6.26M | -64.28M | -90.18M | -8.93M | -97.03M |
Depreciation & Amortization | 15.48M | n/a | n/a | 59.56K | n/a | n/a | 271 | 55.25K | 79.17K | 2.11M | 2.08M | 1.18M | 77.79K | 87K | 86.55K | 81.36K | 88.27K | 96.02K | 73.4K | 103.17K |
Add to Watchlist
Select watchlists to add or remove VCRE